Guofu Ding

Author PubWeight™ 6.82^‹?›

Top papers

Rank	Title	Journal	Year	PubWeight™‹?›
1	Antimalarial artesunate protects sepsis model mice against heat-killed Escherichia coli challenge by decreasing TLR4, TLR9 mRNA expressions and transcription factor NF-kappa B activation.	Int Immunopharmacol	2007	0.92
2	Artesunate protects sepsis model mice challenged with Staphylococcus aureus by decreasing TNF-alpha release via inhibition TLR2 and Nod2 mRNA expressions and transcription factor NF-kappaB activation.	Int Immunopharmacol	2009	0.90
3	Artesunate enhances the antibacterial effect of {beta}-lactam antibiotics against Escherichia coli by increasing antibiotic accumulation via inhibition of the multidrug efflux pump system AcrAB-TolC.	J Antimicrob Chemother	2011	0.89
4	CpG ODN107 potentiates radiosensitivity of human glioma cells via TLR9-mediated NF-κB activation and NO production.	Tumour Biol	2012	0.89
5	Lipopolysaccharide could be internalized into human peripheral blood mononuclear cells and elicit TNF-alpha release, but not via the pathway of toll-like receptor 4 on the cell surface.	Cell Mol Immunol	2004	0.84
6	The antimalarial artemisinin synergizes with antibiotics to protect against lethal live Escherichia coli challenge by decreasing proinflammatory cytokine release.	Antimicrob Agents Chemother	2006	0.84
7	Leucine-rich repeat 11 of Toll-like receptor 9 can tightly bind to CpG-containing oligodeoxynucleotides, and the positively charged residues are critical for the high affinity.	J Biol Chem	2012	0.81
8	The newly identified CpG-N ODN208 protects mice from challenge with CpG-S ODN by decreasing TNF-alpha release.	Int Immunopharmacol	2007	0.76